Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Early studies suggest that radiofrequency-based renal denervation reduces blood pressure in patients with moderate hypertension. We investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the ab...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2018-06, Vol.391 (10137), p.2335-2345
Hauptverfasser: Azizi, Michel, Schmieder, Roland E, Mahfoud, Felix, Weber, Michael A, Daemen, Joost, Davies, Justin, Basile, Jan, Kirtane, Ajay J, Wang, Yale, Lobo, Melvin D, Saxena, Manish, Feyz, Lida, Rader, Florian, Lurz, Philipp, Sayer, Jeremy, Sapoval, Marc, Levy, Terry, Sanghvi, Kintur, Abraham, Josephine, Sharp, Andrew S P, Fisher, Naomi D L, Bloch, Michael J, Reeve-Stoffer, Helen, Coleman, Leslie, Mullin, Christopher, Mauri, Laura
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Early studies suggest that radiofrequency-based renal denervation reduces blood pressure in patients with moderate hypertension. We investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(18)31082-1